If you are demanding any product or service please register as Farmavita.Net network member and publish your offer or demad.
In-Licensing and oursoucing of products is usual a way for development of winning portfolio of products. License-in is also very cost effective way of product/technology development.
Opportunities are listed according chronological order, the most recent first.
A pharmaceutical company from Turkey, selling finished product of Quercetin complex and dossiers. Manufacturing site is TurkeyQuercetin complex includes the important bioflavonoid quercetin in a synergistic formula with vitamin C and bromelain to provide unique antioxidant protection as well as natural seasonal support. Has antioxidant properties which help to stabilize cell membranes. Offers the additional benefits of incorporating acerola...
Active substance formulated into Tivortin® – L-arginine amino acid — is the only substrate for nitric oxide (NO) synthesis in humans.
Tivortin® aspartate is a potent vasodilator, vascular tone regulator.
Tivortin® aspartate is a universal angioprotector:
♦ reduces activation and adhesion of leukocytes to the endothelium;
♦ has antithrombotic properties, reduces platelets adhesion, their activation and aggregation;
1. An entirely new combination. An original analgesic, which is not a scheduled drug.
2. The combination is in complete compliance with a global trend of multimodal analgesia.
3. The option for adequate pain control (equivalent to morphine) achieved with low doses and with minimal complications and adverse effects.
The conditions for licensing-out selling of the product.
1. Documents to be transferred:
GxP audits (GMP,GDP, GLP, GCP,etc.), facility feasibility audits, GAP analysis audits, supply security audits,computer system validations and CVS audits, GxP training
Adalimumab API available: - from EU cGMP certified facility
- exceptional quality
- fill-finish possibilities
Please ask for more info.
Profitable and Modern Russian CMO with long term contracts for sale Founded in 2011, State of the art, audited by TOP MNC pharma companies, CMO located in Moscow area with comfortable transport junction, Long-term contract manufacturing agreements (packaging) with 5+ TOP MNC pharmaceutical companies. Total area - 1.600 m2, including equipment stock, analytical laboratory and microbiological laboratory. CMO contracts includes primary and...
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
Member of Farmavita.net is looking to in-lincese Dossier and contract manufacture for:
Lactulose, 100, 200, 300, 500 and 1000 ml (Clear, viscous liquid, colourless or pale brownish yellow)
Dossier and Marketing Authorization: approval in UK and Ireland. File can be shared.
Annual forecast Lactulose solution:
300ml: 500,000 packs
500ml: 950,000 packs
For more details, please contact us at firstname.lastname@example.org
Kind regards, ...
OUT-LICENSING HYBRID DOSSIER OF ALIMEMAZINE TABLETS OF 20 MG (GENERIC OF THERALAN / SANOFI), WITH B.E. STUDIES finalized in December 2016. THE DOSSIER IS AVAILABLE FOR OUT-LLICENISNG AND SUPPLY FOR ALL COUNTRIES EXCEPT FOR THE NORDICS (SE, NO, FI, DK). THE STRENGHT OF 20 MG IS UNIQUE AND EVEN THE INNOVATOR DOES NOT HAVE IT. PLEASE KINDLY CONTACT ME FOR MORE DETAILS. THANK YOU IN ADVANCE! BEST REGARDS.
Objective: To enter into EU domain grabbing a regulatory compliant pharmaceutical manufacturing unit under running condition. The option can be high-end products as well as Nutraceutical manufacturing unit
Strategy: Purchase of few Marketing Authorizations relevant to EU region. Subsequent procurement of the products through contract sales, till manufacturing unit gets in place, selling the products to marketing arm, who should have strong...
Objective: To enter into EU domain procuring Marketing Authorizations for high-end products
Strategy: Purchase of few Marketing Authorizations relevant to EU region. Subsequent procurement of the products through contract sales, till manufacturing unit gets in place, selling the products to marketing arm, who should have strong presence in the region, and may act as a business partner as well (JV), with or without equity...
OUT-LICENSING DOSSIER OF ALIMEMAZINE TABLETS OF 5 MG, 10 MG AND 20 MG (GENERIC OF THERALAN / SANOFI), WITH B.E. STUDIES.
THE DOSSIER IS AVAILABLE FOR OUT-LLICENISNG AND SUPPLY FOR ALL COUNTRIES EXCEPT FOR THE NORDICS (SE, NO, FI, DK). THE STRENGHT OF 20 MG IS UNIQUE AND EVEN THE INNOVATOR DOES NOT HAVE IT. PLEASE KINDLY CONTACT ME FOR MORE DETAILS. THANK YOU IN ADVANCE! BEST REGARDS.
Lokking for EU CTD Dossiers for traditional herbal pharmaceuticals, without supply.